QR Code

Real-world treatment patterns and effectiveness of palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer aged 75 years or older

BackgroundElderly patients are generally underrepresented in oncology clinical trials; therefore, real-world data are needed to inform clinical management of elderly patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2−) metastatic breast cancer (mBC)....

Full description

Saved in:
Main Authors: Adam Brufsky, Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Rachel M. Layman, Hope S. Rugo
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Oncology
Subjects:
palbociclib
elderly
real-world
metastatic breast cancer
HR+/HER2−
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1237751/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items